Category: Peterson-KFF

Analysis: COVID-19 Ranks as a Top 3 Leading Cause of Death in the U.S., Higher than in Almost All Other Peer Countries

A new KFF analysis examines leading causes of death and mortality rates in the United States and comparable countries. The U.S. has a higher COVID-19 mortality rate than many of its peer countries, with COVID-19 ranking as the nation’s third-leading ca…

The Pandemic’s Effect on the Widening Gap in Mortality Rate between the U.S. and Peer Countries

A new KFF brief looks at where COVID-19 falls as a leading cause of death in the U.S. compared to similarly large and wealthy countries. The analysis finds that COVID-19 mortality rates are the third leading cause of death in the U.S., a ranking shared…

The Cost of Inpatient and Outpatient Care Drives High Health Spending in the U.S. Relative to Other Countries, New Analysis Finds

A new KFF issue brief compares the main drivers of health spending in the United States and other large, wealthy countries, and finds that the cost of inpatient and outpatient care – much more so than prescription drugs or administrative costs – drives…

What Do We Know About Spending Related to Public Health in the U.S. and Comparable Countries?

A new chart collection examines what we know about public health spending in the U.S. and comparable countries. The chart collection explores high-level trends in spending on public health and prevention in the U.S., and finds that while the U.S. spend…

What Do We Know About People with High Out-of-Pocket Spending?

Based on an analysis of claims data, this slideshow examines overall trends, gender and age of high out-of-pocket spenders in large employer health plans, as well as differences in out-of-pocket health expenditures across diseases.

Who is Most Likely to Have High Prescription Drug Costs?

This slideshow explores prescription drug spending for people who are covered by large employer health plans.

What Drives Health Spending in the U.S. Compared to Other Countries

A new issue brief looks at the drivers of health spending in the U.S., and key differences between the U.S. and other large, wealthy nations. The analysis finds that the cost of inpatient and outpatient care (which encompasses primary care, services at…

Cost-Sharing Waivers and Premium Relief by Private Plans in Response to COVID-19 (Nov. 2020 Update)

An updated issue brief estimates the number of enrollees in individual and fully-insured group market plans that have waived cost-sharing – out-of-pocket costs including coinsurance, copayments, and deductibles – for COVID-19 treatment. The analysis al…

How Private Insurers Are Using Telehealth to Respond to the Pandemic

Private insurance plans have taken a variety of steps to expand telemedicine uptake and access during the COVID-19 pandemic. A new issue brief on the Peterson-KFF Health System Tracker examines four actions private insurers have taken to promote telehe…

The Veterans Health Administration’s Role During the COVID-19 Response

A new issue brief examines the role of the Veterans Health Administration (VHA) during the coronavirus pandemic, and public health emergencies more broadly. The analysis finds that the VHA has provided assistance to 46 states and D.C., including treati…